iZumi's plans to capitalize on iPS cells.
Baker
Monya
M
Nature Reports Stem Cells, San Francisco, USA.
D001709:Biotechnology / Q000191:economics*; D049674:History, 21st Century; D006801:Humans; D007221:Industry; D018973:Intellectual Property; D039904:Pluripotent Stem Cells